GPX4 and cancer: reported that simvastatin (SIM) could weaken 3-hydroxy-3-methylglutaryl-CoA reductase to inhibit the mevalonic acid pathway and GPX4 expression, thereby inducing ferroptosis in TNBC cancer cells (105).